Levitra 20 mg Tablets: An In-Depth Guide

Accessing Levitra in Malaysia
Secondary Outcome
Frequently asked questions
Related/similar drugs
References (13)
Trial summary

Accessing Levitra in Malaysia

A fourth oral erectile-dysfunction drug, apomorphine (Uprima®, TAP Pharmaceuticals), has been approved in Europe, and TAP Pharmaceuticals applied to the FDA for its approval at the end of 2002. It is a dopamine receptor agonist and works through an entirely different mechanism. Although the drug received the support of an FDA advisory panel in April 2000 (as reported by heartwire ), TAP Pharmaceuticals withdrew apomorphine's new drug application soon after, due to concerns that it caused fainting spells.

Optum Perks

The impact of a shortage of Medicine in Pakistan: Causes and solutions

Call your doctor for medical advice about side effects.

Product	Dosage	Quantity + Bonus	Price
Levitra Generic	10mg	360 + 10 Pills	407.94€ 388.51€
Levitra Generic	20mg	180 + 10 Pills	293.10€ 279.14€
Levitra Soft Tabs	20mg	20 Pills	74.68€ 71.12€
Levitra Generic	10mg	180 + 10 Pills	246.74€ 234.99€
Levitra Generic	40mg	20 Pills	67.56€ 64.34€
Levitra Generic	60mg	30 + 2 Pills	109.43€ 104.22€
Levitra Soft Tabs	20mg	90 + 6 Pills	241.31€ 229.82€
Levitra Generic	40mg	30 + 2 Pills	93.58€ 89.12€
Levitra Professional	20mg	180 + 4 Pills	502.31€ 478.39€
Levitra Generic	40mg	180 + 10 Pills	405.06€ 385.77€
Levitra Generic	40mg	90 + 6 Pills	234.73€ 223.55€
Levitra Soft Tabs	20mg	360 + 20 Pills	682.21€ 649.72€
Levitra Generic	10mg	20 Pills	46.54€ 44.32€
Levitra Soft Tabs	20mg	180 + 10 Pills	398.14€ 379.18€
Levitra Generic	40mg	10 Pills	41.37€ 39.40€
Levitra Generic	20mg	120 + 10 Pills	224.15€ 213.48€
Levitra Generic	60mg	20 Pills	81.30€ 77.43€

You may report side effects to FDA at 1-800-FDA-1088.

Region	Price Range (per tablet)	Available Brands
North America	$10 - $25	Bayer, Generic versions
Europe	€8 - €20	Bayer, Generics
Asia	$5 - $15	Bayer, Local generic brands
Australia	AUD 15 - AUD 35	Bayer, Other authorized generics

Do not use Levitra with similar medications such as avanafil (Stendra), sildenafil (Viagra), or tadalafil (Cialis). Tell your doctor about all other medications you use for erectile dysfunction.

Secondary Outcome

"Balancing the Pill Bottle: Unveiling the Pros and Cons of Deregulating Non-Essential Drug Prices in Pakistan"

This list is not complete and many Other drugs may interact with vardenafil.

Frequently asked questions

Stop using Levitra and call your doctor at once if you have: ringing in your ears, or sudden hearing loss; ringing in your ears, or sudden hearing loss; swelling in your hands, ankles, or feet; swelling in your hands, ankles, or feet; a light-headed feeling, like you might pass out; or a light-headed feeling, like you might pass out; or flushing (sudden warmth, redness, or tingly feeling); flushing (sudden warmth, redness, or tingly feeling); This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Do not use Levitra with similar medications such as avanafil (Stendra), sildenafil (Viagra), or tadalafil (Cialis). Tell your doctor about all other medications you use for erectile dysfunction.

ScriptSave WellRx

This list is not complete and many Other drugs may interact with vardenafil. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Levitra only for the for the indication prescribed. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Concomitant Medications

Efficacy of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA treatment improved the patient's erectiondate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA improved the patient's erection after Minimum and Maximum Intervals between LEVITRA intake and the start of intercoursedate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Reporting a second successful intercourse within 24 hours of dosingdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Patients prefer LEVITRA over last Erectile Dysfunction treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Tolerability of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionYesSafety Issue: )]TJ /C2_0 1 Tf 0 Tc 0 Tw 7.98 0 0 7.98 49.405 366.8227 Tm <004A>Tj /TT1 1 Tf 12 0 0 12 52.705 361.3027 Tm ( )Tj /TT0 1 Tf 0.0001 Tc -0.0001 Tw 0.28 0 Td ( Flexible dose studies started all )Tj 0 Tc 0 Tw 13.055 0 Td [(patients at LEVITRA 10 m)7.8 (g)-5 ( and allo)]TJ -0.0002 Tc -0.0005 Tw 14.83 0 Td (wed decrease in dose to 5 mg or )Tj 0.0001 Tc -0.0001 Tw -27.66 -1.145 Td (increase in dose to 20 mg based on side effects and efficacy. )Tj 0 Tc -0.0006 Tw -0.78 -1.655 Td (Back pain was reported in 2.0% of patients treated)Tj 0 Tw ( with LEVITRA and 1.7% of patients on placebo. )Tj 0.0001 Tc -0.0026 Tw 0 -1.315 TD (Placebo-controlled trials suggested )Tj 0.0002 Tc -0.001 Tw 14.25 0 Td (a dose effect in the incidence of)Tj 0.0004 Tc -0.0016 Tw 12.71 0 Td [( som)8.2 (e)-0.8 ( adverse events $headache, )]TJ -0.0003 Tw -26.96 -1.15 Td (flushing, dyspepsia, nausea, rhinitis$ over the )Tj 0.0001 Tc 0.0004 Tw 18.37 0 Td [(5 mg, 10 m)7.9 (g, and 20 m)7.9 (g doses of LEVITRA. The )]TJ 0.0008 Tc -0.0018 Tw -18.37 -1.15 Td [(f)3.8 (o)0.8 (llowing se)4.6 (ction identif)3.8 (i)-1.4 (es add)5.8 (ition)5.8 (a)4.6 (l, less f)3.8 (r)-1.2 (equ)5.8 (e)]TJ 0.001 Tc 19.99 0 Td [(nt events $<)5 (2%$ repo)6 (rte)4.8 (d)1 ( during th)6 (e clin)6 (ical )]TJ 0.0006 Tc -0.002 Tw -19.99 -1.15 Td [(developm)8.4 (ent of LEVITRA. Excluded from)8.4 ( this list ar)]TJ -0.0027 Tw 21.44 0 Td [(e those events that are infrequ)5.6 (e)4.4 (nt and m)8.4 (i)-1.6 (nor, )]TJ 0.0003 Tc -0.0009 Tw -21.44 -1.145 Td [(those events that m)8.1 (a)-0.9 (y be commonly observed in the )]TJ 0.0001 Tc -0.0013 Tw (absence of drug therapy, a)Tj 0.0003 Tc -0.0015 Tw 31.49 0 Td (nd those events that are )Tj -0.0001 Tc 0.0001 Tw -31.49 -1.155 Td (not reasonably associated with the drug. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Related/similar drugs

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Levitra only for the for the indication prescribed. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Levitra 20 mg Bayer is a popular choice for erectile health issues.
It should not be used in combination with certain medications like alpha-blockers.
Men with heart conditions should consult a doctor prior to use.
The pill’s onset can vary between individuals, typically about 30 minutes.
It is not an aphrodisiac, and sexual arousal is necessary for effectiveness.
Levitra 20 mg Bayer is not intended for recreational use.
The medication’s effectiveness can be influenced by age and health status.
Overdose symptoms may include priapism, a painful erection lasting several hours.
Pregnant or breastfeeding women should avoid using Levitra.
Proper hydration can help reduce some side effects.
Keep out of reach of children and protected from moisture.

Levitra 20 mg Bayer is manufactured by Bayer Pharmaceuticals.
It is often marketed under the brand name Levitra.
The medication can be prescribed for men with erectile dysfunction.
Levitra works by relaxing blood vessel muscles.
It is available in tablet form for oral use.
The recommended dose is usually 10-20 mg depending on need.
Generics of Levitra 20 mg Bayer might be available in some markets.
Patients should avoid heavy meals close to taking the medication.
Common side effects may include nasal congestion and upset stomach.
Levitra 20 mg Bayer may interact with certain blood pressure medicines.
Always follow your doctor’s instructions when using Levitra.

)Tj 0 Tc -0.0006 Tw -0.78 -1.655 Td (Back pain was reported in 2.0% of patients treated)Tj 0 Tw ( with LEVITRA and 1.7% of patients on placebo. )Tj 0.0001 Tc -0.0026 Tw 0 -1.315 TD (Placebo-controlled trials suggested )Tj 0.0002 Tc -0.001 Tw 14.25 0 Td (a dose effect in the incidence of)Tj 0.0004 Tc -0.0016 Tw 12.71 0 Td [( som)8.2 (e)-0.8 ( adverse events $headache, )]TJ -0.0003 Tw -26.96 -1.15 Td (flushing, dyspepsia, nausea, rhinitis$ over the )Tj 0.0001 Tc 0.0004 Tw 18.37 0 Td [(5 mg, 10 m)7.9 (g, and 20 m)7.9 (g doses of LEVITRA.

References (13)

)Tj 0 Tc 0.0037 Tw 1.5 -1.315 Td (BODY AS A WHOLE: anaphylactic)Tj 0.0008 Tc -0.0015 Tw 14.775 0 Td [( reaction $in)5.8 (cluding lary)5.8 (ngeal edem)8.6 (a$, asthen)5.8 (ia, f)8.8 (ace edem)8.6 (a, )]TJ 0.0009 Tc 0 Tw -14.775 -2.3 Td (pain )Tj 0.0004 Tc -0.0004 Tw 0 -2.805 TD [(AUDITOR)-2.6 (Y)2.6 (: tinnitus )]TJ -0.0003 Tc 0.0003 Tw 0 -1.31 TD [(CARDIOVASCULAR:)-7.5 ( angina pectoris, ches)]TJ 0.0003 Tc -0.0003 Tw 18.11 0 Td [(t pain, hypertension, hypotension, m)8.1 (yocardial )]TJ 0.0005 Tc -0.0005 Tw -18.11 -1.155 Td [(ischem)8.3 (ia, myocardial inf)8.5 (a)-0.7 (rction, palpitation, )]TJ -0.0001 Tc 0.0001 Tw 17.97 0 Td (postural hypotension, s)Tj 0 Tc 0 Tw 9.245 0 Td (yncope, tachycardia )Tj 0.0002 Tc -0.0002 Tw -27.215 -1.31 Td [(DIGESTIVE: abdom)8 (inal pain, abnorm)8 (al liver f)]TJ -0.0027 Tw 18.88 0 Td [(unction tests, diarrhea, dry )-7.5 (m)8 (outh, dysphagia, )]TJ 0.0005 Tc -0.003 Tw -18.88 -1.155 Td [(esophagitis, gastritis, gas)4.7 (t)-1.7 (roesophag)5.5 (e)]TJ 0.0006 Tc -0.0006 Tw 14.83 0 Td [(al reflux, G)7.8 (G)2.8 (TP increas)4.8 (ed, vom)8.4 (iting )]TJ 0.0004 Tc -0.0004 Tw -14.83 -1.32 Td (MUSCULOSKELETAL: arthra)Tj 0.0005 Tc -0.0025 Tw 12.805 0 Td (lgia, back pain, myalgia, neck pain )Tj 0.0001 Tc -0.0017 Tw -12.805 -1.315 Td [(NERVOUS:)-7.1 ( hypertonia, hypesthesia, insom)7.9 (nia)]TJ 0.0002 Tc 18.855 0 Td [(, paresthesia, som)8 (nolence, vertigo )]TJ 0.0004 Tc -0.0004 Tw -18.855 -1.315 Td (RESPIRATORY: dyspnea, ep)Tj -0.0003 Tc 0.0003 Tw 12.09 0 Td (istaxis, pharyngitis )Tj 0 Tc 0.0016 Tw -12.09 -1.32 Td (SKIN AND APPENDAGES: photosensitivity)Tj 0.0002 Tc -0.0014 Tw 18.42 0 Td ( reaction, pruritus, rash, sweating )Tj ET q 1 0 0 1 -8.195038 -34.037292 cm /CS0 CS 0.004 0.004 0.004 SCN 0.75 w 1 j 1 J q 1 0 0 1 61.2 652.08 cm 0 0 m 432 0 l 0.48 -22.68 m 432.48 -22.68 l 0.48 -60.3 m 432.48 -60.3 l 0 -203.7 m 432 -203.7 l S Q Q /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 201 0 obj <>>>/Resources 234 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 202 0 obj <>>>/Resources 236 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 236 0 obj <> endobj 237 0 obj <> endobj 235 0 obj <>stream �5H�8CTzd#E��[��w��ᮆ�)ȼ�7�)��ࢠ1�97��8��{�s ��~�N�4T$�C#A�}�A�_��r�y��XXm�d�=��jc��}�jˇX��(��? Proportion of vardenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm concentrationdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm countdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Proportion of sildenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo and vardenafil after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Washington, DC - The FDA gave approval yesterday to vardenafil (Levitra®, Bayer and Glaxo Smith Kline), an oral erectile-dysfunction drug that works through the same mechanism as sildenafil (Viagra®, Pfizer). Like sildenafil, vardenafil can seriously affect blood pressure and should not be taken by those on buy levitra fast alpha blockers or nitrates. The recommended dose is 10 mg taken one hour before sexual activity, with 20-, 5.0-, and 2.5-mg doses available.

Pharmacotherapy for erectile dysfunction

Vardenafil is a phosphodiesterase inhibitor and, like sildenafil, is strongly contraindicated if patients are taking nitrates (nitroglycerin tablets or patches) or alpha blockers, due to the possibility of a steep drop in blood pressure. Patients with QT prolongation are also advised not to take the drug, as there is a possibility of abnormal heart rhythm in these patients. The FDA warns that men whose underlying cardiovascular status makes sexual activity inadvisable should not take vardenafil. Patients who have suffered an MI or stroke within the last six months or have hypotension or hypertension, unstable angina, severe liver impairment, end-stage renal disease requiring dialysis, or retinitis pigmentosa should not take the drug. "Today's approval of Levitra means there is now an important alternative in the treatment of erectile dysfunction," said Colin J Foster, president, Bayer Pharmaceuticals Corporation, in a press release.

Patient assistance programs

The drug will be comarketed by Glaxo Smith Kline and Bayer, and Bloomberg News reports packaging will feature the "Levitra flame" to help distinguish the round orange pills from Viagra's now-famous blue diamond-shaped ones. Both drugs are likely to soon have a third competitor stateside. Eli Lilly & Co and Icos Corporation intend to introduce tadalafil (Cialis®), another phosphodiesterase inhibitor, to the US market later this year. Tadalafil and vardenafil have both been approved in Europe. Currently, there have been no head-to-head trials comparing effectiveness of the three drugs. The )]TJ 0.0008 Tc -0.0018 Tw -18.37 -1.15 Td [(f)3.8 (o)0.8 (llowing se)4.6 (ction identif)3.8 (i)-1.4 (es add)5.8 (ition)5.8 (a)4.6 (l, less f)3.8 (r)-1.2 (equ)5.8 (e)]TJ 0.001 Tc 19.99 0 Td [(nt events $<)5 (2%$ repo)6 (rte)4.8 (d)1 ( during th)6 (e clin)6 (ical )]TJ 0.0006 Tc -0.002 Tw -19.99 -1.15 Td [(developm)8.4 (ent of LEVITRA. Excluded from)8.4 ( this list ar)]TJ -0.0027 Tw 21.44 0 Td [(e those events that are infrequ)5.6 (e)4.4 (nt and m)8.4 (i)-1.6 (nor, )]TJ 0.0003 Tc -0.0009 Tw -21.44 -1.145 Td [(those events that m)8.1 (a)-0.9 (y be commonly observed in the )]TJ 0.0001 Tc -0.0013 Tw (absence of drug therapy, a)Tj 0.0003 Tc -0.0015 Tw 31.49 0 Td (nd those events that are )Tj -0.0001 Tc 0.0001 Tw -31.49 -1.155 Td (not reasonably associated with the drug. )Tj 0 Tc 0.0037 Tw 1.5 -1.315 Td (BODY AS A WHOLE: anaphylactic)Tj 0.0008 Tc -0.0015 Tw 14.775 0 Td [( reaction $in)5.8 (cluding lary)5.8 (ngeal edem)8.6 (a$, asthen)5.8 (ia, f)8.8 (ace edem)8.6 (a, )]TJ 0.0009 Tc 0 Tw -14.775 -2.3 Td (pain )Tj 0.0004 Tc -0.0004 Tw 0 -2.805 TD [(AUDITOR)-2.6 (Y)2.6 (: tinnitus )]TJ -0.0003 Tc 0.0003 Tw 0 -1.31 TD [(CARDIOVASCULAR:)-7.5 ( angina pectoris, ches)]TJ 0.0003 Tc -0.0003 Tw 18.11 0 Td [(t pain, hypertension, hypotension, m)8.1 (yocardial )]TJ 0.0005 Tc -0.0005 Tw -18.11 -1.155 Td [(ischem)8.3 (ia, myocardial inf)8.5 (a)-0.7 (rction, palpitation, )]TJ -0.0001 Tc 0.0001 Tw 17.97 0 Td (postural hypotension, s)Tj 0 Tc 0 Tw 9.245 0 Td (yncope, tachycardia )Tj 0.0002 Tc -0.0002 Tw -27.215 -1.31 Td [(DIGESTIVE: abdom)8 (inal pain, abnorm)8 (al liver f)]TJ -0.0027 Tw 18.88 0 Td [(unction tests, diarrhea, dry )-7.5 (m)8 (outh, dysphagia, )]TJ 0.0005 Tc -0.003 Tw -18.88 -1.155 Td [(esophagitis, gastritis, gas)4.7 (t)-1.7 (roesophag)5.5 (e)]TJ 0.0006 Tc -0.0006 Tw 14.83 0 Td [(al reflux, G)7.8 (G)2.8 (TP increas)4.8 (ed, vom)8.4 (iting )]TJ 0.0004 Tc -0.0004 Tw -14.83 -1.32 Td (MUSCULOSKELETAL: arthra)Tj 0.0005 Tc -0.0025 Tw 12.805 0 Td (lgia, back pain, myalgia, neck pain )Tj 0.0001 Tc -0.0017 Tw -12.805 -1.315 Td [(NERVOUS:)-7.1 ( hypertonia, hypesthesia, insom)7.9 (nia)]TJ 0.0002 Tc 18.855 0 Td [(, paresthesia, som)8 (nolence, vertigo )]TJ 0.0004 Tc -0.0004 Tw -18.855 -1.315 Td (RESPIRATORY: dyspnea, ep)Tj -0.0003 Tc 0.0003 Tw 12.09 0 Td (istaxis, pharyngitis )Tj 0 Tc 0.0016 Tw -12.09 -1.32 Td (SKIN AND APPENDAGES: photosensitivity)Tj 0.0002 Tc -0.0014 Tw 18.42 0 Td ( reaction, pruritus, rash, sweating )Tj ET q 1 0 0 1 -8.195038 -34.037292 cm /CS0 CS 0.004 0.004 0.004 SCN 0.75 w 1 j 1 J q 1 0 0 1 61.2 652.08 cm 0 0 m 432 0 l 0.48 -22.68 m 432.48 -22.68 l 0.48 -60.3 m 432.48 -60.3 l 0 -203.7 m 432 -203.7 l S Q Q /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 201 0 obj <>>>/Resources 234 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 202 0 obj <>>>/Resources 236 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 236 0 obj <> endobj 237 0 obj <> endobj 235 0 obj <>stream �5H�8CTzd#E��[��w��ᮆ�)ȼ�7�)��ࢠ1�97��8��{�s ��~�N�4T$�C#A�}�A�_��r�y��XXm�d�=��jc��}�jˇX��(��? Proportion of vardenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm concentrationdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm countdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Proportion of sildenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo and vardenafil after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Washington, DC - The FDA gave approval yesterday to vardenafil (Levitra®, Bayer and Glaxo Smith Kline), an oral erectile-dysfunction drug that works through the same mechanism as sildenafil (Viagra®, Pfizer).

Levitra 20 mg Bayer has a proven track record for efficacy.
It’s important to inform your doctor of any side effects experienced.
Lifestyle changes can improve ED alongside medication.
Risk factors for ED include diabetes, obesity, and smoking.
Consultation with a healthcare provider ensures safe use.
Levitra 20 mg Bayer is suitable for many but not all men.
Don’t share your medication with others to avoid misuse.
The tablet’s effects can be unpredictable if taken with certain foods.
Follow-up testing might be needed for underlying medical issues.
The medication is part of a comprehensive sexual health plan.
Use discretion and discretion when discussing medication use.

Like sildenafil, vardenafil can seriously affect blood pressure and should not be taken by those on buy levitra fast alpha blockers or nitrates. The recommended dose is 10 mg taken one hour before sexual activity, with 20-, 5.0-, and 2.5-mg doses available.

Storage Condition	Details
Temperature	Store below 30°C (86°F)
Light Protection	Keep in a dry, opaque container
Humidity	Avoid moisture exposure
Out of reach of children	Yes

Levitra 20 mg Bayer is popular for its reliability and quick action.
It’s important to read the patient information leaflet thoroughly.
This medication is not suitable for children or minors.
Levitra can sometimes cause a drop in blood pressure.
Do not combine Levitra with recreational drugs like poppers.
Men should avoid alcohol for optimal medication efficacy.
Levitra 20 mg Bayer may be part of a broader cardiovascular assessment.
Sexual activity should only be undertaken when fully prepared.
Abstain from heavy physical activity immediately after taking the pill.
Levitra does not cure underlying causes of erectile dysfunction.
Always consult a healthcare professional for persistent ED symptoms.

"Today's approval of Levitra means there is now an important alternative in the treatment of erectile dysfunction," said Colin J Foster, president, Bayer Pharmaceuticals Corporation, in a press release.

Call us: 033 243 01 64 or 079 722 17 96